Adagene Inc (ADAG)
2.27
-0.10
(-4.22%)
USD |
NASDAQ |
Nov 14, 16:00
2.27
0.00 (0.00%)
After-Hours: 20:00
Adagene Enterprise Value: 29.78M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 29.78M |
| November 12, 2024 | 33.32M |
| November 11, 2024 | 32.00M |
| November 08, 2024 | 41.74M |
| November 07, 2024 | 61.22M |
| November 06, 2024 | 59.67M |
| November 05, 2024 | 62.10M |
| November 04, 2024 | 59.89M |
| November 01, 2024 | 57.67M |
| October 31, 2024 | 51.03M |
| October 30, 2024 | 64.31M |
| October 29, 2024 | 62.10M |
| October 28, 2024 | 58.56M |
| October 25, 2024 | 58.12M |
| October 24, 2024 | 53.25M |
| October 23, 2024 | 51.03M |
| October 22, 2024 | 51.48M |
| October 21, 2024 | 44.39M |
| October 18, 2024 | 40.41M |
| October 17, 2024 | 31.55M |
| October 16, 2024 | 30.67M |
| October 15, 2024 | 28.90M |
| October 14, 2024 | 22.70M |
| October 11, 2024 | 18.72M |
| October 10, 2024 | 20.49M |
| Date | Value |
|---|---|
| October 09, 2024 | 19.16M |
| October 08, 2024 | 23.50M |
| October 07, 2024 | 23.59M |
| October 04, 2024 | 22.70M |
| October 03, 2024 | 25.36M |
| October 02, 2024 | 28.46M |
| October 01, 2024 | 21.37M |
| September 30, 2024 | 23.14M |
| September 27, 2024 | 23.94M |
| September 26, 2024 | 24.03M |
| September 25, 2024 | 22.26M |
| September 24, 2024 | 23.59M |
| September 23, 2024 | 24.47M |
| September 20, 2024 | 31.11M |
| September 19, 2024 | 24.47M |
| September 18, 2024 | 18.72M |
| September 17, 2024 | 28.01M |
| September 16, 2024 | 46.61M |
| September 13, 2024 | 79.37M |
| September 12, 2024 | 57.23M |
| September 11, 2024 | 61.66M |
| September 10, 2024 | 62.10M |
| September 09, 2024 | 53.25M |
| September 06, 2024 | 40.41M |
| September 05, 2024 | 51.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-112.38M
Minimum
Oct 31 2022
1.198B
Maximum
Feb 09 2021
111.06M
Average
23.21M
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Zai Lab Ltd | 2.423B |
| China SXT Pharmaceuticals Inc | -8.059M |
| LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | -31.94% |
| Normalized Earnings Yield | -20.33 |